Alex Brown

Contributor   in
Novel Therapeutics  

BOC Sciences is a brand of BOCSCI Inc. We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.

tags:   Endocrinology / Metabolic Disease     Biotech Research     Biologics     Biopharma news     Healthcare     Pharmaceutical industry trends    

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at platform are their own personal points of view, and do not represent neither Contributor's employers, nor

Posts by this author

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

BOC Sciences successfully participated in TIDES USA 2022 from May 9th to 12th, at Hynes Convention Center, Boston. During the four-day exhibition, experts from BOC Sciences and global visitors are engaged in heated discussions concerning novel advances in peptide and amino acid synthesis, discovery, design, and engineering.

What are the ADC drugs?

What are the ADC drugs?

The antibody-drug conjugates (ADCs) market continues to rise globally, but ADCs are not a new thing. Why has ADC been surging for so many years? What kind of "magic" power it has, and what makes its growth path so tortuous? Let's take a brief look at the history of ADCs, their features, opportunities, and challenges.